• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 69-83 of 106 results

1028 Exhibit: Ex 1028 US Food and Drug Administration, Guidance for Industry MS...

Document IPR2023-00478, No. 1028 Exhibit - Ex 1028 US Food and Drug Administration, Guidance for Industry MSSD (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1036 Exhibit: Ex 1036 Jan de Jong, et al

Document IPR2023-00478, No. 1036 Exhibit - Ex 1036 Jan de Jong, et al (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1001 Exhibit: Ex 1001 US Patent No 10,272,083 to Hamdy et al

Document IPR2023-00478, No. 1001 Exhibit - Ex 1001 US Patent No 10,272,083 to Hamdy et al (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1004 Exhibit: Ex 1004 Prosecution History of US Patent No 10,272,083 Part 5

Document IPR2023-00478, No. 1004-5 Exhibit - Ex 1004 Prosecution History of US Patent No 10,272,083 Part 5 (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1021 Exhibit: Ex 1021 Daniel W Pierce, et al

Document IPR2023-00478, No. 1021 Exhibit - Ex 1021 Daniel W Pierce, et al (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1006 Exhibit: Ex 1006 PCT International Publication No WO2013010868 to Barf, et...

Document IPR2023-00478, No. 1006 Exhibit - Ex 1006 PCT International Publication No WO2013010868 to Barf, et al (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1023 Exhibit: Ex 1023 Prosecution History of US Patent No 9,758,524 Part 1

Document IPR2023-00478, No. 1023 Exhibit - Ex 1023 Prosecution History of US Patent No 9,758,524 Part 1 (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1003 Exhibit: Ex 1003 Declaration Of Sylvia D Hall Ellis, PhD

Document IPR2023-00478, No. 1003 Exhibit - Ex 1003 Declaration Of Sylvia D Hall Ellis, PhD (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1009 Exhibit: Ex 1009 Ranjana H Advani, et al

Document IPR2023-00478, No. 1009 Exhibit - Ex 1009 Ranjana H Advani, et al (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1039 Exhibit: Ex 1039 TASIGNA® nilotinib Prescribing Information

Document IPR2023-00478, No. 1039 Exhibit - Ex 1039 TASIGNA® nilotinib Prescribing Information (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1024 Exhibit: Ex 1024 US Food and Drug Administration Good Review Practice

Document IPR2023-00478, No. 1024 Exhibit - Ex 1024 US Food and Drug Administration Good Review Practice (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1018 Exhibit: Ex 1018 Akintunde Akinleye, et al

Document IPR2023-00478, No. 1018 Exhibit - Ex 1018 Akintunde Akinleye, et al (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1026 Exhibit: Ex 1026 International Conference on Harmonisation

Document IPR2023-00478, No. 1026 Exhibit - Ex 1026 International Conference on Harmonisation (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1008 Exhibit: Ex 1008 Bruce D Cheson, et al

Document IPR2023-00478, No. 1008 Exhibit - Ex 1008 Bruce D Cheson, et al (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1020 Exhibit: Ex 1020 Jennifer R Brown, et al

Document IPR2023-00478, No. 1020 Exhibit - Ex 1020 Jennifer R Brown, et al (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze
<< 1 2 3 4 5 6 7 8 >>